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Summary
Dopamine-glutamate interactions in theneostriatumde-
termine psychostimulant action, but the underlyingmo-
lecular mechanisms remain elusive. Here we found that
dopamine stimulation by cocaine enhances a heterore-
ceptor complex formation between dopamineD2 recep-
tors (D2R) and NMDA receptor NR2B subunits in the
neostriatum in vivo. The D2R-NR2B interaction is direct
and occurs in the confined postsynaptic density micro-
domain of excitatory synapses. The enhanced D2R-
NR2B interaction disrupts the association of Ca2+/
calmodulin-dependent protein kinase II (CaMKII) with
NR2B, reduces NR2B phosphorylation at a CaMKII-
sensitive site (Ser1303), and inhibits NMDA receptor-
mediated currents in medium-sized striatal neurons.
Furthermore, the regulatedD2R-NR2Binteraction iscrit-
ical for constructing behavioral responsiveness to co-
caine. Our findings here uncover a direct and dynamic
D2R-NR2B interaction in striatal neurons in vivo. This
type of dopamine-glutamate integration at the receptor
level may be responsible for synergistically inhibiting
theD2R-mediatedcircuits in thebasalgangliaand fulfill-
ing the stimulative effect of psychostimulants.
Introduction
Ionotropic glutamate receptors play a significant role in
the regulation of a variety of cellular and synaptic activ-
ities, including learning and memory (Zorumski and
Izumi, 1998), the effectiveness of addictive and neuro-
toxic properties of drugs of abuse (Wolf, 1998; Kalivas,
2004; Nestler, 2005), and phenotypes of various forms
*Correspondence: wangjq@umkc.eduof neurodegenerative diseases (Sattler and Tymianski,
2001). The major members of ionotropic glutamate
receptors include NMDA receptor (NMDAR) and non-
NMDAR (AMPA and kainate) subclasses. Each subclass
of receptors is a heteromultimer of core subunits that
form a functional ion channel. NMDARs are assembled
with the obligatory NR1 subunit and one or more modu-
latory NR2A–D subunits. Various subunit compositions
determine the channel property and function.
Protein phosphorylation is an important mechanism
for the posttranslational modulation of glutamate recep-
tor function (Wang et al., 1993; Wang and Salter, 1994;
Lau and Huganir, 1995; Rostas et al., 1996). Similar to
NR1 (Tingley et al., 1997), NR2B is phosphorylated at
C-terminal Ser1303 (Omkumar et al., 1996) and several
tyrosine sites (Wang and Salter, 1994; Nakazawa et al.,
2001). The Ser1303 phosphorylation is driven by Ca2+/
calmodulin-dependent protein kinase II (CaMKII), an
abundant kinase in the postsynaptic density (PSD) of
glutamatergic synapses (Kelly et al., 1984), or protein
kinase C (PKC) (Liao et al., 2001). Available evidence
consistently shows that the NR2B phosphorylation at ei-
ther serine or tyrosine sites positively regulates NMDAR-
mediated currents (Lieberman and Mody, 1994; Wang
and Salter, 1994; Liao et al., 2001; Rostas et al., 1996)
and affects NMDAR signaling via regulating receptor
trafficking and interactions with synaptic scaffold/
signaling proteins (Hall and Soderling, 1997; Dunah
et al., 2004; Chung et al., 2004).
The neostriatum is a major structure in the basal
ganglia regulating extrapyramidal motor and cognitive
behaviors. This structure has also been the focus of ex-
perimental studies aimed to illustrate brain mechanisms
for psychostimulant actions (Hyman and Malenka, 2001;
Nestler, 2005). Activation of dopaminergic transmission
in this region has been well documented to mediate ef-
fects of dopamine stimulants (Koob and Nestler, 1997;
Berke and Hyman, 2000; Vanderschuren and Kalivas,
2000). Similarly, glutamatergic transmission plays an ac-
tive role in drug actions (Wolf, 1998; Wang and McGinty,
1999; Kalivas, 2004) as the striatum is abundantly inner-
vated with glutamatergic afferents, and NMDARs, prin-
cipally NR1 and NR2B subunits, are densely expressed
in striatal neurons (Standaert et al., 1999; Landwehr-
meyer et al., 1995; Chen and Reiner, 1996; Kuppen-
bender et al., 2000). It is known that the two transmitter
systems intimately interact with each other to mediate
drug actions, but the molecular mechanisms underlying
their interactions are poorly understood.
We therefore investigated dopamine-glutamate inter-
actions by examining phosphorylation of a prevalent
NMDAR subunit (NR2B) in the striatum after dopamine
stimulation in vivo. We found that acute cocaine specif-
ically reduced Ser1303 phosphorylation via a dopamine
D2 receptor (D2R)-mediated mechanism. Interestingly,
D2Rs directly interacted with NR2B and disrupted the
NR2B-CaMKII binding, leading to inhibition of Ser1303
phosphorylation. Furthermore, the D2R-NR2B inter-
action was critical for modulating NMDAR-mediated
currents and behavioral responsiveness to cocaine.
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898Figure 1. Cocaine Reduces NR2B Phosphor-
ylation at Ser1303 in the Rat Striatum
(A and B) Cocaine dose-dependently re-
duced basal levels of pNR2B-Ser1303, but
not NR2B and b-actin, in the CPu and NAc.
Cocaine was injected at three different doses
(10, 20, or 40 mg/kg, i.p.) and rats were sacri-
ficed 30 min after saline or cocaine injection.
Representative immunoblots are shown
above the quantified data. The solid arrows
indicate pNR2B-Ser1303 bands whereas
open arrows indicate weak cross-reactive
bands detected by the anti-pNR2B-Ser1303
antibody.
(C and D) Cocaine time-dependently reduced
basal levels of pNR2B-Ser1303, but not
NR2B, in the CPu and NAc. Cocaine was in-
jected at 30–40 mg/kg (i.p.) and rats were
sacrificed at indicated time points after saline
or cocaine injection. Data are presented as
means 6 SEM from five to six experiments.
*p < 0.05 versus saline.Results
Reduction of NR2B Phosphorylation: Generality,
Specificity, and Spatiotemporal Characteristics
To examine the effect of cocaine on NR2B phosphoryla-
tion, we measured changes in phosphorylation of NR2B
at Ser1303 and Tyr1336 in the striatum following acute
cocaine stimulation in vivo. Phospho-site-specific anti-
bodies were used to detect these changes (see Figure S1
in the Supplemental Data for a validation of the selectiv-
ity of these antibodies). A single intraperitoneal (i.p.)
injection of cocaine (10, 20, or 40 mg/kg) dose-depen-
dently reduced pNR2B-Ser1303 levels in both the dorsal
(caudate putamen, CPu) and ventral (nucleus accum-
bens, NAc) striatum (Figures 1A and 1B). Cocaine at all
doses showed no effect on total levels of NR2B or b-
actin. Thus, the reduction of the phospho-NR2B pro-
teins resulted from decreased phosphorylation rather
than a reduced amount of NR2B. Cocaine at all doses
did not significantly alter pNR2B-Tyr1336 levels in the
dorsal and ventral striatum (data not shown) in contrast
to the profound decrease in pNR2B-Ser1303 levels.
Thus, cocaine selectively decreases NR2B phosphory-
lation at a serine site. To disclose the kinetic property
of the cocaine effect, we performed a time course study
in which cocaine at 30–40 mg/kg was injected and rats
were sacrificed at three different time points after drug
injection. We found that cocaine induced a rapid and re-
versible reduction of Ser1303 phosphorylation (Figures
1C and 1D). At all time points surveyed, cocaine showed
no effect on total NR2B and b-actin expression.
In the above dose-response and time course studies,
the reduction of Ser1303 phosphorylation was not con-fined to the CPu nor the NAc of the striatum. In addition
to the striatum, other forebrain and midbrain areas were
tested for changes in Ser1303 phosphorylation. Cocaine
(10, 20, or 40 mg/kg, i.p., 30 min) did not alter pNR2B-
Ser1303 and NR2B levels in the frontal cortex, the hippo-
campus, the ventral tegmental area, or the amygdala
(Figure S2). Thus, cocaine induced a region-specific
inhibition of NR2B phosphorylation in the striatum.
The Role of Dopamine Receptors in Regulating
NR2B Phosphorylation
Cocaine is known to stimulate dopamine receptors
through enhanced synaptic dopamine availability in
the striatum by blocking the reuptake of released dopa-
mine into the presynaptic terminal (Hurd and Unger-
stedt, 1989; Kalivas and Duffy, 1993). There are two ma-
jor classes of dopamine receptors: a D1 class (D1 and
D5 subtypes) and a D2 class (D2, D3, and D4 subtypes),
with the D1 and D2 subtypes being the most highly en-
riched in the mammalian striatum (Gerfen, 2000). To
evaluate the role of D1Rs and D2Rs in mediating the co-
caine effect, we measured effects of a D1R or D2R selec-
tive antagonist on the cocaine inhibition of Ser1303
phosphorylation. In a first attempt to examine roles of
D1Rs and D2Rs in regulating constitutive NR2B phos-
phorylation, we found that neither the D1R antagonist
SCH23390 (0.1 mg/kg) nor the D2R antagonist eticlo-
pride (0.5 mg/kg) altered basal levels of pNR2B-Ser1303
in the CPu and NAc (Figure 2A). Thus, under normal
conditions, endogenous dopaminergic tone on D1Rs
or D2Rs has a minimal influence over NR2B phosphory-
lation. Furthermore, SCH23390 had no effect on the
cocaine-induced reduction of pNR2B-Ser1303 levels
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899Figure 2. Activation of D2Rs Mediates the Cocaine Inhibition of NR2B-Ser1303 Phosphorylation in the CPu and NAc
(A) SCH23390 (SCH) or eticlopride (Eti) did not affect basal levels of pNR2B-Ser1303 and NR2B. Rats were given a single dose of SCH23390
(0.1 mg/kg, i.p.) or eticlopride (0.5 mg/kg, i.p.) and were sacrificed 30 min after drug injection. (B) Eticlopride, but not SCH23390, blocked the
cocaine-induced decreases in pNR2B-Ser1303. (C and D) Quinpirole (Quin), but not SKF81297 (SKF), reduced pNR2B-Ser1303 levels. (E)
SCH23390, but not eticlopride, blocked the cocaine-stimulated ERK1/2 phosphorylation in the CPu. (F) SKF81297, but not quinpirole, increased
ERK1/2 phosphorylation in the CPu. In (B) and (E), SCH23390 (0.1 mg/kg, i.p.) or eticlopride (0.5 mg/kg, i.p.) was injected 15 min prior to an i.p.
injection of saline or cocaine (40 mg/kg), and rats were sacrificed 30 min after cocaine injection. In (C), (D), and (F), rats were given a single dose of
SKF81297 (1 mg/kg, i.p.) or quinpirole (1 mg/kg, i.p.) or a combination of the two agonists and were sacrificed 30 min after drug injection. Rep-
resentative immunoblots are shown to the left of the quantified data of pNR2B-Ser1303 (A and B) or pERK2 (E). Data are presented as means6
SEM for three to six experiments. *p < 0.05 versus saline + saline (B and E) or saline (C, D, and F). +p < 0.05 versus saline + cocaine.(Figure 2B). In contrast, eticlopride blocked the cocaine
inhibition of NR2B phosphorylation indistinguishably in
the CPu and NAc (Figure 2B). To control the selectivity
and effectiveness of the two antagonists in blocking
their targets, the effect of these antagonists on a D1-
dependent and D2-independent event, phosphorylation
of extracellular signal-regulated kinase 1/2 (ERK1/2) in
the striatum following acute cocaine stimulation (Valjent
et al., 2000; Zhang et al., 2004) was tested in the same
samples. We found that SCH23390 completely blocked,
whereas eticlopride had no effect on, the cocaine-stimulated ERK1/2 phosphorylation in the CPu (Fig-
ure 2E), as opposed to their effects on the cocaine-
induced inhibition of NR2B phosphorylation. These data
validate the selectivity of these antagonists and thereby
support a model in which selective activation of D2Rs
mediates the inhibitory effect of cocaine on NR2B
phosphorylation.
We next tested whether D1R or D2R activation with
their selective agonists affects Ser1303 phosphoryla-
tion. Injection of the full D1R agonist SKF81297 (1 mg/kg,
i.p.) alone did not change basal levels of pNR2B-Ser1303
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900in the CPu (Figure 2C) and NAc (Figure 2D). In contrast,
the D2R agonist quinpirole (1 mg/kg, i.p.) alone mark-
edly reduced pNR2B-Ser1303 levels in the striatum (Fig-
ures 2C and 2D) without changing the total amount of
NR2B (Figures 2C and 2D). Coadministration of these
two agonists produced a similar result as that observed
after injection of quinpirole alone (Figures 2C and 2D). In
addition, SKF81297 increased, whereas quinpirole did
not alter, basal levels of phosphorylated ERK1/2 pro-
teins in the CPu (Figure 2F). Thus, an enhanced dopami-
nergic tone on D2Rs rather than D1Rs suppresses
Ser1303 phosphorylation.
D2Rs and NR2B Subunits Are Coclustered
in Striatal PSD
Ultrastructural studies found theD2R existent in thepost-
and perisynaptic membrane of corticostriatal axospi-
nous glutamatergic synapses in the rat striatum (Hersch
et al., 1995; Wang and Pickel, 2002). We then extended
these morphological observations to a biochemical
analysis in the subcellular PSD fraction isolated from
the striatum for investigating the presence of D2Rs in
the PSD and the physical association of D2Rs with
NR2B. The immunoblot with an anti-D2R antibody re-
vealed a predominant specific band of w70 kDa and a
much lighter band ofw50 kDa (Wang and Pickel, 2002)
in the PSD and P2 fractions, which were blocked by
preabsorption of the antibody with an immunogen pep-
tide (Figure 3A). The specific bands mostly enriched in
the PSD and P2 fractions were also seen for the NR1 sub-
unit, the NR2B subunit, and CaMKIIa, three known PSD
constituents (Figure 3B). The purity of the PSD fraction
was confirmed by the lack of immunoreactivity for
PKC3, a known PKC isozyme present exclusively in the
presynaptic compartment (Figure 3B). To determine
whether D2Rs and NR2B interact with each other in the
PSD, coimmunoprecipitation studies were performed
using the PSD fraction. A clear and specific D2R band
presented in NR2B precipitates (Lane 4 in Figure 3C). In
a reverse coimmunoprecipitation, a specific NR2B
band was also detected in D2R precipitates (Lane 4 in
Figure 3D). These specific bands did not appear when ei-
ther the precipitating antibody was omitted (Lane 2) or
when an irrelevant IgG was used (Lane 3). In contrast,
D1R immunoreactivity was not detectable in either
NR2B (Figure 3C) or D2R precipitates (Figure 3D), and
a specific NR2B or D2R band was not present in D1R
precipitates, even though D1Rs could be precipitated
from striatal PSD fraction (data not shown). These results
reveal a constitutive formation of a heteroreceptor
complex containing D2Rs and NR2B in the PSD micro-
domain of striatal neurons in vivo. Similarly, a D2R
band was seen in NR2B precipitates in the PSD fraction
from the hippocampus and the frontal cortex (Figure S3),
indicating an existence of the D2R-NR2B interaction in
broad areas.
To identify a specific D2R region responsible for the
D2R-NR2B complex formation, glutathione-S-transfer-
ase (GST) fusion proteins were prepared from se-
quences within two intracellular domains of D2Rs: the
carboxyl tail (D2RCT) and the third intracellular loop
(D2RIL3). The D2RIL3 fragment was based on the long, in-
stead of the short, form of D2Rs because D2R-long is
preferentially involved in postsynaptic signaling (Usielloet al., 2000; Lindgren et al., 2003). Using a pull-down as-
say, the ability of GST-D2RCT and GST-D2RIL3 fusion
proteins to recognize and precipitate NR2B from solubi-
lized striatal tissue (P2) was tested. We found that GST-
D2RIL3, but not GST-D2RCT or GST alone, precipitated
NR2B (Figure 3E). GST alone and the two GST fusion
proteins did not precipitate D1Rs (Figure 3F). Thus, the
prime D2R region for D2Rs to complex with NR2B is
restricted to the D2RIL3 region. Similarly, using GST-
NR2BCT and GST-NR1-1aCT fusion proteins, we found
that the former, but not the latter or GST alone, precipi-
tated D2Rs (Figure 3G). GST-NR1-1aCT could only pre-
cipitate D1Rs (Figure 3H) as reported previously (Lee
et al., 2002). Thus, NR2B interacts with D2Rs through
its carboxyl tail. In contrast to D2Rs, D3Rs did not
seem to interact with NR2B because GST-D3RIL2 and
GST-D3RIL3 did not precipitate NR2B (Figure S4).
Direct Protein-Protein Interaction between D2Rs
and NR2B
To define whether the D2R-NR2B interaction is direct
and to reveal the region of D2RIL3 involved in the inter-
action, we conducted blot overlay and in vitro binding
assays using purified GST-D2RIL3 and NR2BCT proteins.
The direct interaction of NR2BCT with D2RIL3 was dem-
onstrated in blot overlay experiments, in which NR2BCT
bound with GST-D2RIL3 but not GST-D3RIL3 (Figure 3J),
whereas D2RIL3 bound with GST-NR2BCT but not GST-
NR1-1aCT (Figure 3K). Furthermore, NR2BCT selectively
bound with GST-D2RIL3-1, but not GST-D2RIL3-2 (Figures
3I and 3J), indicating that the N-terminal 32 amino acid
residue (I210-K241) of D2RIL3 is a critical binding region
to NR2BCT. These results were further confirmed in
in vitro binding assays (Figure 3L). GST-D2RIL3 and
GST-D2RIL3-1, but not GST-D2RIL3-2, GST-D3RIL3, or
GST alone, precipitated NR2BCT in these assays. All
blots were probed in parallel with a GST antibody to as-
sure equivalent protein loading (data not shown).
A sufficient binding motif within the first 32 residues of
D2RIL3 was further identified in competition assays. As
shown in Figures 3M and 3N, purified peptides that
contain a motif of ten residues (TKRSSRAFRA), includ-
ing D2RIL3-P1, -P2, -P3, and -P5 peptides, blocked the
D2RIL3-NR2BCT binding, whereas the D2RIL3-P4 peptide
lacking this motif had no effect. The D2RIL3-P6 peptide
(a sequence-scrambled control of D2RIL3-P5) did not al-
ter the D2RIL3-NR2BCT binding, supporting the idea that
the binding is sequence-specific. Noticeably, the bind-
ing motif identified here represents a distinct region
within the first 32 D2RIL3 amino acids that is conserved
in different species and is adjacent to a calmodulin bind-
ing domain (I210-V223) reported previously (Bofill-
Cardona et al., 2000). However, D2RIL3-P5 is believed
to have no effect on the D2RIL3-calmodulin binding be-
cause the truncated D2RIL3 peptides encompassing
D2RIL3-P5 did not bind to calmodulin (Bofill-Cardona
et al., 2000).
Cocaine Facilitates the D2R-NR2B Association
More coimmunoprecipitation studies were conducted to
assess changes of the D2R-NR2B association in striatal
extracts (P2) in response to cocaine stimulation in vivo.
Cocaine (30 mg/kg, 30 min) increased the level of D2Rs
in NR2B precipitates (Figure 4A) and the level of NR2B
D2 Regulation of NR2B-NMDA Receptors
901Figure 3. Association of D2Rs and NR2B in Striatal Neurons
(A) Immunoblots carried out in the PSD and P2 fractions using an anti-D2R antibody with or without an immunogen (IM) peptide: a 28 amino acid
fragment (284–311, LSSTSPPERTRYSPIPPSHHQLTLPDPS) within D2RIL3.
(B) Immunoblots carried out in the different fractions of striatal protein extractions. Proteins were loaded at 5 mg per lane.
(C and D) Coimmunoprecipitation (IP) of NR2B and D2Rs in striatal PSD. Immunoblot (IB) results (L4) showed that NR2B coprecipitated with
D2Rs (C) and vice versa (D). D1Rs coprecipitated with neither NR2B nor D2Rs. Lane 1 represents non-IP samples and no specific band was pres-
ent in lanes 2 and 3 due to the lack of immunoprecipitating antibodies in samples (L2) and the use of an irrelevant IgG (L3).
(E–H) Pull-down assays with GST or GST fusion proteins from solubilized rat striatal tissue.
(I) Mapping of the NR2BCT binding region in D2RIL3. Two GST fusion proteins containing D2RIL3 portions as indicated were generated and
purified.
(J and K) Blot overlay assays showing NR2BCT binding to GST-D2RIL3-1 and GST-D2RIL3 (J) and D2RIL3 binding to GST-NR2BCT (K).
(L) In vitro binding assays showing NR2BCT binding to GST-D2RIL3-1 and GST-D2RIL3.
(M) The NR2B binding motif in D2RIL3. The primary sequence of the first 32 amino acids of D2RIL3 is shown. Underlined and bold letters indicate
the potential NR2BCT binding motif.
(N) In vitro binding assays showing the blockade of NR2BCT-D2RIL3 binding upon the addition of D2RIL3 peptides (P1, P2, P3, and P5).in D2R precipitates (Figure 4B). In rats pretreated with
eticlopride (0.5 mg/kg), cocaine no longer induced a sig-
nificant increase in the amount of D2Rs in NR2B precip-
itates (Figure 4C). In contrast, SCH23390 (0.1 mg/kg) did
not alter the ability of cocaine to increase D2R levels in
NR2B precipitates (Figure 4D). These data indicate adynamic elevation of the interaction between D2Rs and
NR2B following selective activation of D2Rs by cocaine.
The effect of cocaine seems to be region-specific be-
cause no change in the D2R-NR2B coimmunoprecipita-
tion was found in the hippocampus and the frontal cortex
following cocaine administration (Figure S5).
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of Ser1303 Phosphorylation
CaMKII is an abundant kinase in the PSD (Kelly et al.,
1984). This kinase and PKC drive NR2B Ser1303 phos-
phorylation in hippocampal neurons or Xenopus oo-
cytes (Omkumar et al., 1996; Liao et al., 2001). To identify
the kinase(s) that can phosphorylate Ser1303 in the na-
tive NR2B in striatal neurons, dephosphorylated striatal
homogenates were incubated in the phosphorylation
mixture, which contained recombinant human PKA,
PKC, or CaMKIV, or rat brain CaMKII. PKA and CaMKIV
failed to alter Ser1303 phosphorylation and PKC slightly
increased it (Figure 5A). Strikingly, CaMKII induced
a nearly 3-fold increase in Ser1303 phosphorylation (Fig-
ure 5A). The CaMKII effect was blocked by the CaMKII
inhibitor KN93 (20 mM)—but not its inactive analog
KN92 (Figure 5B)—and by a CaMKII peptide inhibitor
(Chang et al., 1998) at 100 nM (data not shown). These
results reveal that in striatal neurons CaMKII is a key
kinase driving NR2B phosphorylation at Ser1303.
We then examined changes in CaMKII activity in stria-
tal tissue in response to cocaine stimulation. Acute co-
caine injection (30 mg/kg) induced a rapid and transient
reduction of CaMKII activity (Figure 5C), which corre-
sponded well with the kinetic of reduced Ser1303 phos-
Figure 4. Coimmunoprecipitation of D2Rs with NR2B in Striatal
Neurons Following Cocaine Stimulation
(A and B) Cocaine increased the association of D2Rs with NR2B. Im-
munoblots were performed on NR2B or D2R immunoprecipitates.
Saline or cocaine (30 mg/kg, i.p.) was given 30 min before sacrifice.
Representative immunoblots are shown to the left of the quantified
data in terms of optical density ratios. Data are presented as means
6 SEM for four to six experiments. (C and D) Effects of eticlopride (C)
and SCH23390 (D) on the cocaine-induced formation of the D2R-
NR2B complex. Eticlopride, but not SCH23390, blocked an increase
in the D2R level in NR2B precipitates. Eticlopride (0.5 mg/kg, i.p.) or
SCH23390 (0.1 mg/kg, i.p.) was injected 15 min prior to an i.p. injec-
tion of saline or cocaine (30 mg/kg), and rats were sacrificed 30 min
after cocaine injection. *p < 0.05 versus saline (A and B) or saline +
saline (C). +p < 0.05 versus saline + cocaine.phorylation. The reduction was sensitive to the D2R
antagonist eticlopride (Figure 5D), but not the D1R
antagonist SCH23390. In an effort to detect changes in
a known direct association of CaMKII with NR2B (Gar-
doni et al., 1998), we found that cocaine decreased the
amount of CaMKIIa and phospho-CaMKIIa-Thr286 in
NR2B precipitates (Figure 5E). In a reverse immuno-
precipitation, a lower level of NR2B was also seen in
CaMKIIa precipitates. Thus, cocaine seems to reduce
CaMKII-NR2B binding and CaMKII activity, which
may account for the cocaine inhibition of Ser1303
phosphorylation.
D2Rs Inhibit NMDAR-Mediated Currents
To determine whether D2Rs can modulate NMDAR
function, we recorded whole-cell NMDAR-mediated cur-
rents in acutely dissociated, medium-sized striatal neu-
rons. We found that quinpirole at 10, but not 0.1, mM
significantly reduced NMDAR currents in 13 out of
21 neurons surveyed (Figures 6A and 6B). The reduction
of NMDAR currents appears to be reversible since re-
duced NMDAR currents showed a trend toward recov-
ery after quinpirole was washed off (Figure 6B). The
quinpirole effect was mediated by D2Rs because bath
perfusion of eticlopride (1 mM) blocked the depression
of NMDAR currents induced by quinpirole in all neurons
tested (Figures 6C and 6D, n = 16). A critical role of the
identified direct protein-protein interaction between
D2Rs and NR2B in the modulation of NMDAR currents
by D2Rs is illustrated in Figures 6E and 6F. Intracellular
application of the D2RIL3-P5 peptide (20 mM) prevented
the inhibition of NMDAR currents induced by quinpirole
(n = 20). In contrast, the control D2RIL3-P6 peptide had
no such effect, and quinpirole (10 mM) still significantly
reduced NMDAR current in 14 out of 27 cells recorded.
The Role of D2R-NR2B Interaction in Behavioral
Responsiveness to Cocaine
We extended our molecular observations to behavioral
experiments to investigate whether the cocaine-regu-
lated D2R-NR2B interaction can translate to the modula-
tion of the regulation of behavioral responsiveness to co-
caine. Cocaine is well known to require activation of both
D1Rs and D2Rs, followed by activation of the direct
(striatonigral) pathway and suppression of the indirect
(striatopallidal) pathway, respectively, to increase the
outflow of the basal ganglia, which leads to motor stim-
ulation. We then speculate that, following cocaine stim-
ulation, concomitant activation of D2Rs and inhibition
of NR2B-containing NMDARs occurs in D2R/NR2B-
bearing neurons through the D2R-NR2B integration,
and that this process is required for synergistically sup-
pressing the indirect pathway. Consistent with this
model, in open field locomotor activity assays, the D2R
agonist quinpirole (1 mg/kg) augmented behavioral re-
sponses to cocaine (15 mg/kg, Figure 7A). Interestingly,
the systemically active NR2B selective antagonist
RO25-6981 (IC50 of 9 nM and 52 mM for NR1/NR2B and
NR1/NR2A, respectively) (Fischer et al., 1997), which
itself did not alter spontaneous motor activity (Fig-
ure 7B), mimicked the effect of quinpirole in eliciting
significantly higher behavioral responses to cocaine
as measured by horizontal activity (Figure 7C) and ste-
reotypy (Figure 7D). The latter was characterized by
D2 Regulation of NR2B-NMDA Receptors
903Figure 5. Phosphorylation of NR2B at
Ser1303 by CaMKII
(A) Phosphorylation of Ser1303 by protein ki-
nases. An aliquot (30 mg) of striatal homoge-
nates was subjected to dephosphorylating
conditions (deP) or to dephosphorylating
conditions followed by phosphorylation by
PKA, PKC, CaMKII, or CaMKIV at 50 ng (5
min, 30C). (B) The CaMKII inhibitor blocked
the CaMKII-regulated Ser1303 phosphoryla-
tion. Following the dephosphorylation of
striatal homogenates, KN93 or KN92 at
20 mM in combination with CaMKII (50 ng)
was added into the phosphorylation mixture
for a 5 min incubation (30C). (C) Effects of co-
caine on CaMKII activity assayed on synapto-
some-enriched fractions of striatal tissue.
Rats were injected with cocaine (30 mg/kg,
i.p.) and sacrificed at indicated time points af-
ter cocaine injection. (D) Eticlopride blocked
the reduction of CaMKII activity by cocaine.
Eticlopride (0.5 mg/kg, i.p.) was injected 15
min prior to an i.p. injection of saline or co-
caine (30 mg/kg) and rats were sacrificed 30
min after cocaine injection. (E) Coimmuno-
precipitation of NR2B with CaMKIIa and
phospho-CaMKIIa-Thr286 in striatal tissue
(P2) from rats treated with saline or cocaine
(30 mg/kg, i.p., 30 min before tissue collec-
tion). Immunoblots were performed on
NR2B precipitates. Representative immuno-
blots are shown to the left of the quantified
data (A, B, and E). Data are presented as
means 6 SEM from five to six experiments
(A and B) or five to eight animals per group
(C–E). *p < 0.05 versus deP (A), basal levels
(B), or saline (C–E). +p < 0.05 versus CaMKII
alone (B) or saline + cocaine (D).intensive sniffing and biting. Another NR2B selective an-
tagonist, ifenprodil (1–2 mg/kg), produced the same ef-
fect (Figure S6A). Quinpirole and RO25-6981, when co-
administered at their subthreshold doses, at which
they did not significantly alter the cocaine effect, signifi-
cantly enhanced a locomotor activity induced by cocaine
(Figure 7E). Thus, D2R activation and NR2B inhibition
could synergistically augment behavioral responsive-
ness to cocaine. The motor stimulation from cocaine
alone or in combination with RO25-6981 requires D2R
activation because the D2R antagonist eticlopride (0.5
mg/kg) blocked motor activity induced by cocaine or co-
caine + RO25-6981 (Figure 7F). To determine whether the
effect of systemic RO25-6981 primarily occurs in the
local striatum, a microinjection study targeting the NAc
or the CPu was performed in chronically prepared and
freely moving rats. Microinjection of this agent into the
NAc produced the same effect as that observed follow-
ing systemic injections (Figure 7G). So did microinjection
of this agent into the CPu (Figure S6B). In sharp contrast
to the NR2B antagonist, the relatively NR2A selective an-
tagonist NVP-AAM077 (Auberson et al., 2002; but Neyton
and Paoletti, 2006) failed to augment a behavioral re-
sponse to cocaine when given locally (Figure 7G) or sys-
temically (Figure 7I). In fact, NVP-AAM077 at 2 mg/kg sig-
nificantly reduced spontaneous and cocaine-stimulated
motor activity (Figure 7I). These data support the notion
that the D2R-NR2B interaction synergistically inhibits
the indirect pathway and thereby controls behavioral
responsiveness to cocaine.To define the direct role of the D2R-NR2B interaction,
we synthesized systemically active and cell-permeable
Tat-fusion peptides (Tat-D2RIL3-P5, with demonstrated
ability to disrupt the D2R-NR2B binding, and its control,
Tat-D2RIL3-P6). Using fluorescently tagged peptides
(FITC-Tat-D2RIL3-P5), we detected the presence of
these peptides in striatal neurons after a single intrave-
nous (i.v.) injection (3 nmol/g). Striatal concentration of
the peptide increased in a time-dependent manner and
peaked 90 min after injection (Figure 8A). Pretreatment
with the interference peptide Tat-D2RIL3-P5 (3 nmol/g,
i.v., 90 min before cocaine) prevented the elevation of
the D2R-NR2B interaction induced by cocaine (Fig-
ure 8B). Tat-D2RIL3-P5 also reversed the reduction of
the CaMKII-NR2B interaction (Figure 8C) and Ser1303
phosphorylation (Figure 8D) induced by cocaine. Pre-
treatment with the control peptide (Tat-D2RIL3-P6) had
no such effects (Figures 8B–8D). Moreover, Tat-
D2RIL3-P5, but not Tat-D2RIL3-P6, markedly attenuated
cocaine-stimulated horizontal activity (Figure 8E) and
stereotypy (Figure 8F). The two peptides had no effect
on the basal CaMKII-NR2B binding and Ser1303 phos-
phorylation, although Tat-D2RIL3-P5 reduced the basal
D2R-NR2B interaction to 71.4% of control (p < 0.05).
No noticeable behavioral side effects were observed
with peptide treatment. These results provide strong ev-
idence supporting a critical role of the D2R-NR2B inter-
action in mediating cocaine’s effect on CaMKII-NR2B
binding and Ser1303 phosphorylation and in construct-
ing a full-scale motor response to cocaine.
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NMDAR-Mediated Currents in Acutely Disso-
ciated Striatal Neurons
(A) Representative traces indicating that bath
application of the D2R agonist quinpirole at
10 mM (upper traces), but not 0.1 mM (lower
traces), reduced NMDAR currents.
(B) Time courses of the quinpirole effect on
NMDAR currents.
(C) Representative traces elucidating the
blockade of the quinpirole-induced reduction
of NMDAR currents by bath application of the
D2R antagonist eticlopride (1 mM). A time
course graph is shown below the representa-
tive traces.
(D) Summary data showing the inhibition of
NMDAR currents by quinpirole (10 mM) in
the absence and presence of eticlopride
(1 mM).
(E and F) Application of D2RIL3-P5, but not
D2RIL3-P6, peptide (20 mM) in intracellular
fluid (ICF) blocked the quinpirole inhibition
of NMDAR currents. Data are presented as
means 6 SEM (n = 14 to 27). *p < 0.05 versus
control.Discussion
Both dopamine and glutamate receptors are densely ex-
pressed in striatal neurons. Active interactions between
them are believed to occur at the receptor level. Indeed,
the results obtained from this study reveal the direct
binding between the third intracellular loop of D2Rs
and the C-terminal region of NR2B. This interaction is re-
sponsive to cocaine stimulation, and the upregulated in-
teraction seems to be involved in the reduction of both
CaMKII binding to NR2B and NR2B Ser1303 phosphor-
ylation. Electrophysiological studies provide evidence
supporting D2R inhibition of NMDAR currents through
interactions with NR2B. Behaviorally, the D2R-NR2B
interaction is critical for behavioral responses to acute
cocaine administration.
Dopamine-Glutamate Interactions Control
Psychostimulant Actions
The dopamine-glutamate interaction is a key factor in
determining stimulant actions. Recent studies focus
on molecular mechanisms underlying the interaction.
Available data show that dopamine stimulation can reg-
ulate total levels or trafficking of NMDARs, AMPA recep-
tors, and glutamate receptor anchoring proteins, such
as PSD-95 and Homer, in striatal neurons (Dunahet al., 2004; Szumlinski et al., 2004; Yao et al., 2004; Bou-
dreau and Wolf, 2005). Both dopamine and glutamate
also regulate the phosphorylation state of dopamine-
and cAMP-regulated phosphoprotein with molecular
weight 32 kDa (DARPP-32) in striatal neurons (reviewed
in Svenningsson et al., 2005). Moreover, a direct protein-
protein coupling has been shown to enable functional
crosstalk between D1Rs and the NR1 subunit (Lee
et al., 2002; Fiorentini et al., 2003). All these models of
dopamine-glutamate interactions are believed to con-
tribute to the development of various forms of synaptic
and behavioral plasticity in response to stimulants.
The results from the present study add another dopa-
mine-glutamate interaction model in which D2Rs and
NR2B functionally crosstalk to control neuronal and
behavioral responses to cocaine.
Direct D2R-NR2B Interactions in Striatal Neurons
A noteworthy finding in this study is the direct inter-
action between D2Rs and NR2B in striatal neurons.
This interaction is responsive to enhanced dopaminer-
gic inputs in vivo by cocaine and is believed to occur
postsynaptically because the interaction was revealed
in the isolated PSD microdomain and modulated
NMDAR currents in dissociated striatal neurons. The
specific population(s) of striatal neurons that
D2 Regulation of NR2B-NMDA Receptors
905Figure 7. A Synergistic Effect of the D2R Agonist and the NR2B Antagonist on Behavioral Responses to Cocaine in the Open Field
(A) Coadministration of quinpirole (Quin, 1 mg/kg, i.p.) augmented cocaine-stimulated horizontal activity. (B) Effects of the NR2B-NMDAR selec-
tive antagonist RO25-6981 (RO) at 0.5, 1, or 2 mg/kg (i.p.) on spontaneous motor activity. (C and D) Coadministration of RO25-6981 (0.5 and
1 mg/kg, i.p.) augmented cocaine-stimulated horizontal activity (C) and stereotypy time (D). (E) Quinpirole and RO25-6981 at their subthreshold
doses (0.25 mg/kg for quinpirole and 0.1 mg/kg for RO25-6981, i.p.) synergistically augmented cocaine-stimulated horizontal activity. (F) Effects
of eticlopride (0.5 mg/kg, i.p.) on horizontal activity induced by cocaine or RO25-6981 (1 mg/kg, i.p.) + cocaine. Saline or eticlopride was given
15 min prior to cocaine, RO25-6981, or cocaine + RO25-6981. (G) Intra-accumbal (i.a.) injection of RO25-6981, but not the NR2A-NMDAR selec-
tive antagonist NVP-AAM077 (NVP), augmented cocaine-stimulated horizontal activity. RO25-6981 (2.5 mg/0.4 ml/side) or NVP-AAM077
(2.5 mg/0.4 ml/side) was injected 5 min prior to systemic injection of cocaine. (H) Locations of microinjection sites within the nucleus accumbens.
Representative sites are illustrated on only one side of the slice (interaural distance = 10.0 mm) for the bilateral injections of vehicle (filled circles)
and RO25-6981 (filled squares) in cocaine-treated rats used in (G). Scale bar, 1 mm. (I) Effects of coadministration of NVP-AAM077 (1 or 2 mg/kg,
i.p.) on cocaine-stimulated horizontal activity. Cocaine was injected i.p. at 15 mg/kg in all studies. Data are expressed as means 6 SEM of
behavioral activity measured for 60 (A–C) or 40 (D–G and I) min after cocaine injection (n = 4 to 7 per group). *p < 0.05 versus cocaine (D–G) alone
or the corresponding values in rats without NVP-AAM077 treatment (I). +p < 0.05 versus the corresponding values in rats treated with saline (F).coexpress(es) D2Rs and NR2B may host this interaction.
All striatopallidal projection neurons contain a high level
of D2Rs (Surmeier et al., 1996; Aizman et al., 2000). The
physiological effect of the interaction (i.e., D2R inhibition
of NMDAR currents) was seen in about half of medium-
sized spiny neurons. Thus, striatopallidal efferent neu-
rons likely represent a main subpopulation of striatal
neurons for this event, although the experiments in this
study did not exclude the possibility that a small portion
of striatonigral output neurons that coexpress a low level
of D2Rs (Aizman et al., 2000) or D2R-containing choliner-
gic interneurons may also host this interaction. It is
possible that D2Rs are strategically positioned in the
NR2B-enriched PSD of excitatory synapses for a direct
interaction of two receptors. Ultrastructural observa-
tions seem to support this idea. D2Rs are enriched in
dendritic spine shafts and heads that are contacted bycorticostriatal glutamatergic afferents to form axospi-
nous asymmetric synapses throughout the striatum
(Hersch et al., 1995; Yung and Bolam, 2000). A dense
and widespread membrane localization of D2Rs is pres-
ent outside nigrostriatal dopaminergic symmetric syn-
apses (Graybiel et al., 1981), making it possible for them
to respond to dopamine that has overspilled from its
synaptic cleft (Sesack et al., 2004) or to dopamine extra-
synaptically derived from volume transmission (Hersch
et al., 1995). Together, the data obtained in this study
support a synaptic model for a direct and dynamic re-
ceptor-receptor interaction between the two dominant
receptors in the striatum. This interaction may integrate
with other D2RIL3 binding partners identified previously
(Bofill-Cardona et al., 2000; Bibb, 2005) to control the
cellular response to converging dopamine and gluta-
mate inputs.
Neuron
906Figure 8. Intravenous Administration of the Interference Peptide Tat-D2RIL3-P5 Altered the Cocaine-Stimulated Cellular and Motor Responses
(A) Transduction of Tat-D2RIL3-P5 peptides in the rat striatum. After FITC-Tat-D2RIL3-P5 injection (3 nmol/g, i.v.), animals were perfused with
saline and the concentrations of peptide in striatal tissue were determined at indicated time points.
(B and C) Summary data from coimmunoprecipitation showing the NR2B level in striatal D2R precipitates (B) and the CaMKIIa level in striatal
NR2B precipitates (C).
(D) Summary data from immunoblots showing effects of cocaine on NR2B Ser1303 phosphorylation in the striatum of rats pretreated with
Tat-D2RIL3-P5 or Tat-D2RIL3-P6.
(E and F) Effects of cocaine on horizontal activity (E) and stereotypy (F) in rats pretreated with Tat-D2RIL3-P5 or Tat-D2RIL3-P6. Tat peptides were
given at 3 nmol/g (i.v.) 90 min prior to cocaine (30 mg/kg, i.p.) or saline and rats were sacrificed 35 min after cocaine injection. Data are expressed
as means 6 SEM (n = 3 to 6 per group). *p < 0.05 versus saline + saline. +p < 0.05 versus saline + cocaine.The Role of CaMKII in the Regulation of NR2B
Phosphorylation in Response to Cocaine
CaMKII is known to play a significant role in synaptic
plasticity (Soderling, 2000; Sheng and Kim, 2002). This
role has been tightly related to its ability to regulate
glutamate receptor phosphorylation. In hippocampal
neurons, CaMKII acts as a prime kinase to catalyze con-
stitutive NR2B phosphorylation at Ser1303 (Omkumar
et al., 1996). Similarly, in striatal neurons, CaMKII is the
most potent kinase in upregulating NR2B Ser1303 phos-
phorylation, based on observations in this study. In re-
sponse to cocaine stimulation, CaMKII is also an essen-
tial element in sequential events leading to the D2R
inhibition of NR2B phosphorylation. This was demon-
strated by the findings that cocaine induced a D2R-
dependent reduction of CaMKII activity in a time course
corresponding to the kinetics of reduced Ser1303 phos-
phorylation and reduced the CaMKII binding to NR2B.
Since the disruption of the D2R-NR2B binding with the
Tat-D2RIL3-P5 peptide blocked the cocaine-induced
reduction of both CaMKII-NR2B binding and NR2B
phosphorylation, the direct D2R-NR2B interaction con-
tributes to these cocaine effects. It appears that the
enhanced D2R-NR2B interaction after cocaine may dis-
rupt the CaMKII-NR2B association. This results in the
weakening of CaMKII influence over its specific phos-
phorylation site (Ser1303), leading to reduced Ser1303
phosphorylation.Physiological Effects of the D2R-NR2B Interaction,
a Synaptic Model for Dopamine-Glutamate Synergy
Whether the D2R-NR2B interaction modulates the excit-
ability of NMDARs and determines behavioral respon-
siveness to psychostimulants is particularly intriguing.
The traditional direct and indirect pathways in the basal
ganglia originate from striatonigral and striatopallidal
projection neurons, respectively. Synergistic interac-
tions between striatonigral (stimulation) and striatopalli-
dal (inhibition) neurons are required for motor responses
to psychostimulants. It is known that dopamine and glu-
tamate dynamically interact with each other to deter-
mine the outflow of the two pathways, but the underlying
molecular mechanisms are unclear. The findings in this
study suggest a mechanism which involves a direct
receptor-receptor interaction. When this direct D2R-
NR2B interaction primarily occurs in D2R-enriched stria-
topallidal output neurons, concurrent D2R activation
and NR2B-NMDAR inhibition could take place through
the D2R-NR2B coupling, which could then synergisti-
cally suppress the indirect pathway in response to co-
caine. The suppression of the indirect pathway by this
method cooperates with stimulation of the direct path-
way to jointly determine a final output from the basal
ganglia circuit. The data from the current electrophysio-
logical and behavioral studies are remarkably consistent
with this notion. Electrophysiologically, D2R activation
inhibited NMDAR currents in medium efferent neurons,
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medium neurons in a previous report (Flores-Hernandez
et al., 2002). The direct D2R-NR2B interaction is required
for this inhibition, a mechanism in addition to an indirect
inhibition of NMDAR currents in hippocampal neurons
by D2Rs (Kotecha et al., 2002). Behaviorally, the NR2B
antagonists mimicked the D2R agonist in augmenting
cocaine-stimulated motor activity. Coadministration of
the D2R agonist and the NR2B antagonist at their sub-
threshold doses synergistically potentiated the cocaine
effect. More importantly, the disruption of D2R-NR2B
binding severely impaired the ability of cocaine to pro-
duce a full-scale motor response. It is less likely that
the NR2B-containing NMDAR in D1R-enriched striato-
nigral neurons contributes to these events because (1)
D1Rs showed no association with NR2B in terms of
direct receptor-receptor interaction (Lee et al., 2002;
Fiorentini et al., 2003; this study); and (2) inhibition of
NR2B-NMDARs in D1R-enriched neurons, if there is
any, is more likely to counteract D1R stimulation of the
direct pathway and thus attenuate motor stimulation.
Together, the results from the current study appear to
support a critical role of the D2R-NR2B interaction in
suppressing the D2R-dependent indirect pathway.
This suppression may eventually contribute to a well-
known phenomenon called D1R-D2R synergy, which
was demonstrated in numerous pharmacological stud-
ies and the studies using D1R or D2R knockout mice
(reviewed in Holmes et al., 2004) and is needed for motor
stimulation by psychostimulants.
Experimental Procedures
Animals
Adult male Wistar rats weighting 200–225 g (Charles River, New
York, NY) were individually housed in clear plastic cages in a con-
trolled environment at a constant temperature of 23C and humidity
of 50% 6 10% with food and water available ad libitum. The animal
room was on a 12/12 hr light/dark cycle with lights on at 0700. Rats
were allowed 6 days of habituation to the animal colony before any
treatment began. All animal use procedures were in strict accor-
dance with the NIH Guide for the Care and Use of Laboratory
Animals and were approved by the Institutional Animal Care and
Use Committee.
Cloning, Expression, and Purification of GST Fusion Proteins
The cDNA fragment encoding the D2R C-terminal region (D2RCT,
N430-C443), D2R second intracellular loop (D2RIL2, S129-T153),
D2R third intracellular loop (D2RIL3, K211-Q373), D2RIL3-1 (I210-
V270), D2RIL3-2 (G242-Q373), D3R second intracellular loop
(D3RIL2, S125-A151), D3R third intracellular loop (D3RIL3, R210-
K372), NMDAR NR1-1a subunit C-terminal region (NR1-1aCT;
E834-S938), or NMDAR NR2B subunit C-terminal region (NR2BCT;
E839-V1482) was generated by PCR amplification from full-length
cDNA clones. These fragments were subcloned into BamHI-EcoRI
sites of the pGEX4T-3 plasmid (Amersham Biosciences, Arlington
Heights, IL) or SpeI-XhoI sites of the pET-41a(+) plasmid (Novagen,
Madison, WI). Initiation methionine residues and stop codons were
also incorporated where appropriate. To confirm appropriate splice
fusion, all constructs were resequenced. GST fusion proteins were
expressed in E. coli BL21 competent cells (Amersham) or
BL21(DE3)pLysE competent cells (Novagen) and purified from bac-
terial lysates as described by the manufacturer.
Affinity Purification, or Pull-Down, Assay
The solubilized striatal extracts (50–100 mg of protein) were diluted
with 13 PBS/1% Triton X-100 and incubated with 50% (v/v) slurry
of glutathione-sepharose 4B beads (Amersham) saturated with the
GST protein alone or indicated GST fusion proteins (15 mg) for2–3 hr at 4C. Beads were washed four times with 13PBS/1% Triton
X-100. Bound proteins were eluted with 23 LDS loading buffer and
were resolved by SDS-PAGE and immunoblotted with respective
antibodies.
Blot Overlay Assay
GST fusion proteins were fractionated by SDS-PAGE and trans-
ferred to a PVDF membrane. After blocking (5% milk in PBS and
0.1% Tween 20), the membrane was incubated in 2% milk-PBS
buffer containing 2.5–5 mg/ml of a purified protein probe for 2 hr at
room temperature. The bound protein was revealed by standard
western blot analysis using a respective antibody.
In Vitro Binding Assay
GST-NR2BCT (5 mg) in PBS was digested with 0.2 NIH unit of throm-
bin (Sigma, St. Louis, MO) for 2 hr at room temperature. The reaction
was stopped by adding PMSF (10 mM), and the mixture was incu-
bated for 1 hr at 4C. GST was removed by glutathione-sepharose
(Amersham). The supernatant was equilibrated to a final 13 binding
buffer (200 mM NACl, 0.2% Triton X-100, 0.2 mg/ml BSA, and 50 mM
Tris [pH, 7.5]). Binding reaction was initiated by adding GST-D2RIL3,
GST-D2RIL3-1, GST-D2RIL3-2, or GST-D3RIL3 and incubated for 2–3 hr
at 4C. GST fusion proteins were precipitated using 100 ml of 10%
glutathione-sepharose. The precipitate was washed three times
with 13 binding buffer. Bound proteins were eluted with 23 LDS
loading buffer and were resolved by SDS-PAGE.
Coimmunoprecipitation
Protein samples (PSD or P2 fraction) from the striatum, the hippo-
campus, or the frontal cortex were used for coimmunoprecipitation
(Mao et al., 2005). NR2B and D2R were precipitated using a respec-
tive rabbit polyclonal antibody against NR2B (Chemicon, Temecula,
CA) and D2R (Chemicon) and 50% protein A agarose/sepharose
bead slurry (Amersham). Proteins were separated on Novex 4%–
12% gels and probed with a rabbit antibody against NR2B (Chemi-
con), D2R (Chemicon), D1R (Chemicon), phospho-CaMKIIa-Tyr286
(Santa Cruz Biotechnology, Santa Cruz, CA), or CaMKIIa (Santa
Cruz). HRP-conjugated secondary antibodies and enhanced chem-
iluminescence were used to detect proteins.
Acute Isolation of Striatal Neurons and Electrophysiology
Rat striatal neurons were acutely isolated according to our previ-
ously described technique (Xiong et al., 1999). Briefly, Wistar rats
(1–2 weeks) were anesthetized and sacrificed. The whole brain
was removed and sectioned (400 mm). The slices were then digested
with papain (0.3–0.5 mg/ml). For the isolation, the striatal region was
cut out in a culture dish under a microscope. Single cells were
mechanically dissociated using fire-polished glass pipettes. Elec-
trophysiological recording began approximately 20 min after the
mechanical dissociation.
Whole-cell patch-clamp recordings were performed as described
previously (Xiong et al., 2004). The recordings were only made on
medium-sized neurons, which were easy to distinguish from large-
sized cells based on somatic cross-sectional size and membrane
capacitance. Patch electrodes (2 to w3 MU) were constructed
from thin-walled borosilicated glass. A multibarrel perfusion system
was employed to achieve a rapid exchange of extracellular solu-
tions. Whole-cell currents were recorded using Axopatch 1D or
200B amplifiers (Axon Instruments, Foster City, CA). Data were fil-
tered at 2 kHz and digitized at 5 Hz using a Digidata 1320 DAC unit
(Axon Instruments). The online acquisition was done using pCLAMP
software (Version 8, Axon Instruments). Standard extracellular solu-
tions contained 140 mM NaCl, 5.4 mM KCl, 2.0 mM CaCl2, 20 mM
HEPES, and 10 mM glucose (pH 7.4; 320 to w330 mOsm). The
pipette solution contained 140 mM CsF, 10 mM HEPES, 11 mM
EGTA, 2 mM TEA, 1 mM CaCl2, 2 mM MgCl2, and 4 mM K2ATP (pH
7.3; 300 mOsm). In general, NMDAR currents were activated by
applying NMDA (100 mM) together with glycine (3 mM) every 1 min
to allow for a complete recovery of the channels from desensitiza-
tion. During each experiment, a voltage step of 210 mV from the
holding potential was applied periodically to monitor cell capaci-
tance and access resistance. Recordings in which access resis-
tance or capacitance changed by more than 10% during the exper-
iment were not included in data analysis.
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Locomotion in an open field was evaluated with an infrared photo-
cell-based, automated Opto-Varimex-Micro apparatus (Columbus
Instruments, Columbus, OH) under illuminated conditions in a
sound-attenuated room. Rats were placed in an activity chamber
and were habituated to the chamber environment for 2 hr. Three sen-
sor pairs positioned in x, y (horizontal), and z (vertical, above the an-
imal’s normal height) directions were assigned to each animal cage
to provide information about horizontal and vertical activities, which
were recorded at 5 min intervals before and after drug injection.
Each sensor pair produces 16 infrared light beams intersecting the
animal cage (beam scan rate = 10 Hz). Status about infrared beam
interruptions by presence of animals was transferred from all
sensors to a computer with operating software. Stereotypy was
detected using computer-generated stereotypy time recorded by
Opto-Varimex-Micro monitors, which refers to the total time that ste-
reotypic behaviors (repetitive breaks of a given beam or beams with
an interval less than 1 s) were observed.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/5/897/DC1/.
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